Cytokinetics (CYTK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 82,985 | 36,433 | 42,256 | 125,206 | 66,874 |
| Marketable Securities | 381,075 | 188,679 | 156,475 | 143,685 | 89,375 |
| Receivables | 4,420 | 5,163 | 2,231 | 1,112 | 24 |
| Other current assets | 0 | 0 | 4,554 | 0 | 0 |
| TOTAL | $474,221 | $233,752 | $207,674 | $274,295 | $158,633 |
| Non-Current Assets | |||||
| PPE Net | 13,346 | 4,530 | 3,204 | 3,568 | 3,637 |
| Investments And Advances | 36,954 | 42,650 | 0 | 16,518 | 7,672 |
| Other Non-Current Assets | 9,282 | 8,882 | 300 | 429 | 200 |
| TOTAL | $59,582 | $56,062 | $3,504 | $20,515 | $11,509 |
| Total Assets | $533,803 | $289,814 | $211,178 | $294,810 | $170,142 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 2,607 | N/A | 2,500 |
| Accounts payable and accrued liabilities | 8,050 | 8,160 | 3,764 | 5,253 | 4,236 |
| Accrued Expenses | 19,315 | 12,123 | 15,757 | 17,392 | 18,047 |
| Other current liabilities | 1,049 | 1,124 | 66 | 227 | 415 |
| TOTAL | $31,199 | $26,023 | $22,194 | $32,444 | $33,258 |
| Non-Current Liabilities | |||||
| Long Term Debt | 46,209 | 45,052 | 39,806 | 31,777 | 27,381 |
| Deferred Revenues | N/A | N/A | N/A | 9,572 | 8,060 |
| Other Non-Current Liabilities | 256,012 | 229,676 | 123,244 | 105,747 | 142 |
| TOTAL | $389,221 | $274,728 | $163,050 | $152,524 | $42,523 |
| Total Liabilities | $420,420 | $300,751 | $185,244 | $184,968 | $75,781 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 71,111 | 59,450 | 54,888 | 54,008 | 41,730 |
| Common Shares | 70 | 59 | 55 | 54 | 41 |
| Retained earnings | -992,306 | -865,016 | -743,324 | -646,081 | -518,291 |
| Other shareholders' equity | 149 | 679 | 500 | 343 | 137 |
| TOTAL | $113,383 | $-10,937 | $25,934 | $109,842 | $94,361 |
| Total Liabilities And Equity | $533,803 | $289,814 | $211,178 | $294,810 | $170,142 |